Tiverton Asset Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$101K Hold
5,439
﹤0.01% 644
2019
Q2
$101K Buy
+5,439
New +$101K ﹤0.01% 623